v-Ha-ras Publications

v-Ha-ras Model Page

Filter publications by application: All
Filter publications by model type: All

Author(s)

(Date)

Paper Title

Citation

Model Type

Applications

Full Text

Leder A, et al.
Mouse over for full list
Leder A, Kuo A, Cardiff RD, Sinn E, Leder P
(1990) v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: effects of phorbol esters and retinoic acid. Proc. Natl. Acad. Sci. U.S.A. 87(23):9178-82
Xie Y, et al.
Mouse over for full list
Xie Y, Trouba KJ, Liu J, Waalkes MP, Germolec DR
(2004) Biokinetics and subchronic toxic effects of oral arsenite, arsenate, monomethylarsonic acid, and dimethylarsinic acid in v-Ha-ras transgenic (Tg.AC) mice. Environ. Health Perspect. 112(12):1255-63
Trempus CS, et al.
Mouse over for full list
Trempus CS, Ward S, Farris G, Malarkey D, Faircloth RS, Cannon RE, Mahler JF
(1998) Association of v-Ha-ras transgene expression with development of erythroleukemia in Tg.AC transgenic mice. Am. J. Pathol. 153(1):247-54
Tennant RW, et al.
Mouse over for full list
Tennant RW, French JE, Spalding JW
(1995) Identifying chemical carcinogens and assessing potential risk in short-term bioassays using transgenic mouse models. Environ. Health Perspect. 103(10):942-50
Regier DS, et al.
Mouse over for full list
Regier DS, Higbee J, Lund KM, Sakane F, Prescott SM, Topham MK
(2005) Diacylglycerol kinase iota regulates Ras guanyl-releasing protein 3 and inhibits Rap1 signaling. Proc. Natl. Acad. Sci. U.S.A. 102(21):7595-600
Germolec DR, et al.
Mouse over for full list
Germolec DR, Spalding J, Yu HS, Chen GS, Simeonova PP, Humble MC, Bruccoleri A, Boorman GA, Foley JF, Yoshida T, Luster MI
(1998) Arsenic enhancement of skin neoplasia by chronic stimulation of growth factors. Am. J. Pathol. 153(6):1775-85